 | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Hans Zingg | |
|---|---|
| Alma mater | University of Basel, McGill University |
| Occupation(s) | Professor, Researcher |
Hans H. Zingg is a Professor Emeritus in the Department of Pharmacology and Therapeutics and Wyeth-Ayerst Chair in Women's Health at McGill University in Montreal, Quebec, Canada. [1]
He earned his Doctor of Medicine (M.D.) from the University of Basel in Switzerland, followed by a Doctor of Philosophy (Ph.D.) in Experimental Medicine from McGill University. [2] He then completed post-doctoral training at Harvard Medical School. [1] [3]
He joined McGill University in 1984 and eventually rose to the rank of Full Professor in the Departments of Medicine, Pharmacology and Therapeutics, as well as Obstetrics and Gynecology. [1] [3]
Before becoming the chair of the Department of Pharmacology and Therapeutics from 2002 to 2011, he acted as Director of the Laboratory of Molecular Endocrinology at the old Royal Victoria Hospital and associate director for Fundamental Research at the MUHC Research Institute. [1] [3]
His research mostly addressed the molecular mechanisms of oxytocin. [1] Amongst other things, he showed that the oxytocin, a pituitary hormone, was also produced in the uterus and contributed to labor and childbirth. [4]
He received the Distinguished Scientist Award from the Canadian Society for Clinical Investigations, as well as Senior Scientist Award from the CIHR. [3]
Charles Robert Scriver was a Canadian pediatrician and biochemical geneticist. His work focused on inborn errors of metabolism and led in establishing a Canada-wide newborn metabolic screening program.
The Faculty of Medicine and Health Sciences is one of the constituent faculties of McGill University. It was established in 1829 after the Montreal Medical Institution was incorporated into McGill College as the college's first faculty; it was the first medical faculty to be established in Canada. The Faculty awarded McGill's first degree, and Canada's first medical degree to William Leslie Logie in 1833.
Barry Innis Posner, is a Canadian physician, research scientist and Professor Emeritus in the Departments of Medicine and Anatomy & Cell Biology at McGill University, where he also managed the Polypeptide and Protein Hormone Laboratory.
Virgil Craig Jordan,, is a scientist with American and British citizenship specializing in drugs for breast cancer treatment and prevention. Currently, he is Professor of Breast Medical Oncology, and Professor of Molecular and Cellular Oncology at the University of Texas MD Anderson Cancer Center, Houston, Texas. Previously, he was Scientific Director and Vice Chairman of Oncology at the Lombardi Comprehensive Cancer Center of Georgetown University. Jordan was the first to discover the breast cancer prevention properties of tamoxifen and the scientific principles for adjuvant therapy with antihormones. More recently his work has branched out into the prevention of multiple diseases in women with the discovery of the drug group, selective estrogen receptor modulator (SERMs). Currently, he plans to develop a new Hormone Replacement Therapy (HRT) for post-menopausal women that prevents breast cancer and does not increase the risk of breast cancer.
George P. Chrousos is professor of Pediatrics and Endocrinology Emeritus and former chairman of the Department of Pediatrics at the Athens University Medical School, Greece. Earlier he was senior investigator, director of the Pediatric Endocrinology Section and Training Program, and chief of the Pediatric and Reproductive Endocrinology Branch of the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). He is also clinical professor of Pediatrics, Physiology and Biophysics at Georgetown University Medical School and distinguished visiting scientist, NICHD, NIH. Dr. Chrousos was the first general director of the Foundation of Biomedical Research of the Academy of Athens (2001–2002). He holds the UNESCO Chair on Adolescent Health Care, while he held the 2011 John Kluge Chair in Technology and Society, Library of Congress, Washington, D.C.
The Dr. Paul Janssen Award for Biomedical Research is given annually by Johnson & Johnson to honor the work of an active scientist in academia, industry or a scientific institute in the field of biomedical research. It was established in 2004 and perpetuates the memory of Paul Janssen, the founder of Janssen Pharmaceutica, a Johnson & Johnson subsidiary.
Rima Rozen is a Canadian geneticist who is a professor at McGill University. Her current research focuses on genetic and nutritional deficiencies in folate metabolism and their impact on complex traits.
Masayoshi Yamaguchi is a Japanese scientist and researcher in the biomedical fields related to biochemistry, endocrinology, metabolism, nutrition, pharmacology and toxicology.
Michael Cowley FTSE is an Australian physiologist. He is best known for his mapping of the neural circuits involved in metabolism and obesity and diabetes treatment. He is a professor in the Department of Physiology at Monash University in the Faculty of Biomedical and Psychological Sciences. He is also a director of the Australian diabetes drug development company, Verva Inc, and director of the Monash Obesity & Diabetes Institute] (modi).
Urs Albert Meyer is a Swiss physician-scientist and clinical pharmacologist.
Michel Bouvier is a Canadian biochemist and molecular pharmacologist. He is a professor of biochemistry and molecular medicine at Université de Montréal; a principal investigator and the chief executive officer at the Institute for Research in Immunology and Cancer; and an associate vice-president in Research, Scientific Discovery, Creation, and Innovation at Université de Montréal. His work focuses on the study of cell signaling towards the discovery of new pharmaceutical drugs.
Rhian M. Touyz Koppel MBBCh, MSc (Med), PhD, FRCP, FRSE, FMedSci, FCAHS is a Canadian medical researcher. She is currently serving as the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre in Montreal, Canada, since 2021. A clinician scientist, her research primarily focuses on hypertension and cardiovascular disease.
Michael O. Thorner is David C. Harrison Professor Emeritus of Internal Medicine at the University of Virginia specializing in endocrinology and metabolism. He was previously the chief of the division of endocrinology and metabolism and the chair of the department of internal medicine.
Vassilios Papadopoulos PharmD, PhD, DSc (Hon) is a scholar, researcher, inventor, professor, and university administrator who has served as dean of the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences at the University of Southern California in Los Angeles, California since 2016. He was previously the associate vice president and director of the Biomedical Graduate Research Organization at Georgetown University from 2005 to 2007, and the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Center from 2007 to 2015. He was appointed Dean of the USC School of Pharmacy in 2016.
Gilles Paradis is a consultant physician at the Institut national de santé publique du Québec, professor in the Department of Epidemiology, Biostatistics, and Occupational Health, and Strathcona Chair in Epidemiology at McGill University in Montreal, Quebec, Canada.
Augusto Claudio G. Cuello is Professor in the Department of Pharmacology and Therapeutics and Charles E. Frosst/Merck Chair in Pharmacology at McGill University in Montreal, Quebec, Canada.
David Goltzman is an endocrinologist, Professor of Medicine and Physiology, and A.G. Massabki Chair in Medicine at McGill University in Montreal, Quebec, Canada. He is the Director of the Centre for Bone and Periodontal Research and also holds the position of Senior Scientist at the McGill University Health Centre Research Institute in the Metabolic Disorders and Complications Program.
Namandjé N. Bumpus is an American pharmacologist and the Chief Scientist of the Food and Drug Administration. She was previously director of the department of pharmacology and molecular sciences at Johns Hopkins University School of Medicine, where she holds the E.K. Marshall and Thomas H. Maren professorship in pharmacology. Bumpus is known for her research on the metabolism of antiviral drugs used to treat HIV-1 and how genetic variations in drug-processing enzymes may impact these drugs' efficacy. Bumpus received a Presidential Early Career Award for Scientists and Engineers in 2016.
Suzanne L Dickson is a neurobiologist and Professor of Neuroendocrinology in the Department of Physiology within the Institute of Neuroscience and Physiology at the Sahlgrenska Academy at the University of Gothenburg in Sweden. She graduated from the University of Edinburgh with a B.Sc. (honours) in Pharmacology. Her doctorate research was undertaken at the Babraham Institute with Professor Gareth Leng and she graduated with a Ph.D. in Neuroendocrinology from the University of Cambridge in 1993. She is also an Honorary Professor in the College of Medicine and Veterinary Medicine at the University of Edinburgh.
John Stephen Lazo is an American pharmacologist noted for his work discovering the fundamental mechanisms of action of small molecule therapeutics and the factors that confer drug resistance. He is a professor emeritus of pharmacology at University of Virginia.
   | This biographical article about a Swiss academic is a stub. You can help Wikipedia by expanding it. |
